@article {10.3844/ajisp.2017.180.185,
article_type = {journal},
title = {Clinical Case Report of a Novel Immunotherapeutic Approach to Autism Spectrum Disorders based on an emulsion of Chondroitin Sulfate, Vitamin D3 and Oleic Acid},
author = {Antonucci, Nicola and Pacini, Stefania and Ruggiero, Marco},
volume = {13},
year = {2017},
month = {Aug},
pages = {180-185},
doi = {10.3844/ajisp.2017.180.185},
url = {https://thescipub.com/abstract/ajisp.2017.180.185},
abstract = {In this clinical case report we describe the effects associated with the administration of a supplement constituted by chondroitin sulfate, vitamin D3 and oleic acid (Rerum®) on the symptoms of Autism Spectrum Disorders (ASD). 44 patients (11 females and 33 males) were administered this supplement for a period of two months and variations of symptomatology were evaluated by the Clinical Global Impression of Improvement (CGI-I). 32 out of 44 subjects (73%), showed improvements in the two months of observation. In the group of female subjects, 9 out of 11 (81%) showed improvements and, among these, 6 out of 9 (66%) showed moderate to very considerable improvements. In the group of male subjects, 24 out of 33 (73%) showed improvements and, among these, 22 out of 24 (91%) showed moderate to very considerable improvements. We attribute these remarkable results to the effects of the supplement on the endocannabinoid system as it relates to neuro-inflammation and neuro-immune alterations.},
journal = {American Journal of Immunology},
publisher = {Science Publications}
}